Accès gratuit
Numéro
Med Sci (Paris)
Volume 31, Numéro 6-7, Juin–Juillet 2015
Page(s) 586 - 588
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20153106004
Publié en ligne 7 juillet 2015
  1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007 ; 448 : 427–434. [CrossRef] [PubMed]
  2. Economou M, Filis G, Tsianou Z, et al. Crohn’s disease incidence evolution in North-western Greece is not associated with alteration of NOD2/CARD15 variants. World J Gastroenterol 2007 ; 13 : 5116–5120. [PubMed]
  3. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012 ; 142 : 46–54, e42 ; quiz e30. [CrossRef] [PubMed]
  4. Kaur J., A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014 ; 2014 : 943162. [PubMed]
  5. Chassaing B, Ley RE, Gewirtz AT. Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice. Gastroenterology 2014 ; 147 : 1363–1377, e17. [CrossRef] [PubMed]
  6. Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010 ; 328 : 228–231. [CrossRef] [PubMed]
  7. Carvalho FA, Koren O, Goodrich JK, et al. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe 2012 ; 12 : 139–152. [CrossRef] [PubMed]
  8. Caricilli AM, Picardi PK, de Abreu LL, et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol 2011 ; 9 : e1001212. [CrossRef] [PubMed]
  9. Henao-Mejia J, Elinav E, Jin C, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012 ; 482 : 179–185. [PubMed]
  10. Elinav E, Strowig T, Kau AL, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011 ; 145 : 745–757. [CrossRef] [PubMed]
  11. Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015 ; 519 : 92–96. [CrossRef] [PubMed]
  12. Roberts CL, Keita AV, Duncan SH, et al. Translocation of Crohn’s disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut 2010 ; 59 : 1331–1339. [CrossRef] [PubMed]
  13. Swidsinski A, Ung V, Sydora BC, et al. Bacterial overgrowth and inflammation of small intestine after carboxymethylcellulose ingestion in genetically susceptible mice. Inflamm Bowel Dis 2009 ; 15 : 359–364. [CrossRef] [PubMed]
  14. Johansson ME, Phillipson M, Petersson J, et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA 2008 ; 105 : 15064–15069. [CrossRef]
  15. Chassaing B, Srinivasan G, Delgado MA, et al. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One 2012 ; 7 : e44328. [CrossRef] [PubMed]
  16. Devkota S, Wang Y, Musch MW, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 2012 ; 487 : 104–108. [PubMed]
  17. Suez J, Korem T, Zeevi D, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 2014 ; 514 : 181–186. [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.